Experts provide first framework for treating hypercalcemia of malignancy in adults

Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society's new Clinical Practice Guideline.

Related Keywords

Beirut ,Beyrouth ,Lebanon ,Ann Arbor ,Michigan ,United States ,Texas ,Italy ,Houston ,Canada ,American ,Emily Henderson ,Matthewt Drake ,Catherine Van Poznak ,Gregorya Clines ,Claudio Marcocci ,M Hassan Murad ,Ghada El ,Thomas Piggott ,University Of Pisa ,Pamerican Society For Bone ,Mcmaster University ,Peterborough Public Health In ,Endocrine Society ,American University Of Beirut ,Clinical Practice Guideline Program ,European Society Of Endocrinology ,Stanford University School Of Medicine ,University Of Michigan ,Queens University ,Mineral Research ,Endocrine Society Clinical Practice Guideline ,Clinical Practice ,Clinical Endocrinology ,El Hajj Fuleihan ,American University ,Hajj Fuleihan ,Mayo Clinic ,Cancer Center ,Peterborough Public Health ,Stanford University School ,Clinical Practice Guidelines ,Clinical Practice Guideline ,American Society ,European Society ,Cancer ,Bisphosphonate ,Flood ,One ,Alcitonin ,Calcium ,Chemotherapy ,Bdenosumab ,Ndocrine ,Endocrinology ,Ormone ,Hypercalcemia ,Metabolism ,Ortality ,Multiple Myeloma ,Myeloma ,Adrenal Cancer ,Research ,